Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	isopentenyl-diphosphate delta-isomerase activity	IDI2 IDI1	4.81e-05	2	139	2	GO:0004452
GeneOntologyMolecularFunction	actin binding	VIL1 MICAL1 MYH11 TMOD4 SPIRE1 LCP1 POF1B SHANK3 KPTN MSN TMOD1 DMD	1.34e-04	479	139	12	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal protein binding	VIL1 MICAL1 MYH11 NRCAM VEZT TOGARAM2 TMOD4 SPIRE1 LCP1 USH1C POF1B SHANK3 KPTN MSN KIF20A BRCA2 TMOD1 IQCJ-SCHIP1 DMD	2.24e-04	1099	139	19	GO:0008092
GeneOntologyMolecularFunction	cell adhesion molecule binding	FN1 NRCAM LAMB1 ADGRL1 NECTIN3 LCP1 MSN MICALL1 PTPRF EHD1 SCRIB DMD CDH2	2.88e-04	599	139	13	GO:0050839
GeneOntologyMolecularFunction	isomerase activity	RANBP2 ERCC3 PIGK IDI2 IDI1 PPIL3 NAXE	3.99e-04	192	139	7	GO:0016853
GeneOntologyMolecularFunction	nitric-oxide synthase binding	ARG2 DMD CDH2	4.61e-04	22	139	3	GO:0050998
GeneOntologyBiologicalProcess	dimethylallyl diphosphate metabolic process	IDI2 IDI1	4.51e-05	2	139	2	GO:0050993
GeneOntologyBiologicalProcess	dimethylallyl diphosphate biosynthetic process	IDI2 IDI1	4.51e-05	2	139	2	GO:0050992
GeneOntologyBiologicalProcess	postsynapse organization	NRCAM NECTIN3 SHANK3 CHRNA7 CYFIP2 NEDD8 PTPRF LRRTM4 CDH2 MUSK	5.32e-05	313	139	10	GO:0099173
GeneOntologyBiologicalProcess	regulation of synapse organization	NRCAM ADGRL1 NECTIN3 SHANK3 CHRNA7 CYFIP2 NEDD8 PTPRF LRRTM4 CDH2 MUSK	6.44e-05	387	139	11	GO:0050807
GeneOntologyBiologicalProcess	regulation of synapse structure or activity	NRCAM ADGRL1 NECTIN3 SHANK3 CHRNA7 CYFIP2 NEDD8 PTPRF LRRTM4 CDH2 MUSK	7.73e-05	395	139	11	GO:0050803
GeneOntologyCellularComponent	actin-based cell projection	VIL1 VEZT LCP1 USH1C KPTN MSN SLC7A8 DMD SLC27A4	1.16e-04	278	141	9	GO:0098858
GeneOntologyCellularComponent	postsynaptic membrane	NRCAM NECTIN3 SHANK3 CHRNA7 PTPRF LRRTM4 SCRIB DMD CDH2 MUSK	4.33e-04	405	141	10	GO:0045211
GeneOntologyCellularComponent	postsynaptic specialization membrane	NRCAM NECTIN3 CHRNA7 PTPRF LRRTM4 SCRIB CDH2	4.37e-04	201	141	7	GO:0099634
GeneOntologyCellularComponent	adherens junction	VEZT NECTIN3 POF1B MSN HMCN1 SCRIB CDH2	6.00e-04	212	141	7	GO:0005912
GeneOntologyCellularComponent	stereocilia ankle link	VEZT USH1C	6.66e-04	6	141	2	GO:0002141
GeneOntologyCellularComponent	stereocilia ankle link complex	VEZT USH1C	6.66e-04	6	141	2	GO:0002142
Domain	IsopentenylPP_isomerase_typ1	IDI2 IDI1	5.50e-05	2	139	2	IPR011876
Domain	GOLD_dom	SEC14L6 ACBD3 SEC14L4	3.58e-04	19	139	3	IPR009038
Domain	GOLD	SEC14L6 ACBD3 SEC14L4	3.58e-04	19	139	3	PS50866
Domain	CRAL_TRIO	SEC14L6 ARHGAP8 SEC14L4	4.86e-04	21	139	3	PF00650
Domain	-	SEC14L6 ARHGAP8 SEC14L4	6.41e-04	23	139	3	3.40.525.10
Domain	SEC14	SEC14L6 ARHGAP8 SEC14L4	8.23e-04	25	139	3	SM00516
Domain	CRAL_TRIO	SEC14L6 ARHGAP8 SEC14L4	1.04e-03	27	139	3	PS50191
Domain	TMOD	TMOD4 TMOD1	1.13e-03	7	139	2	IPR004934
Domain	DUF3585	MICAL1 MICALL1	1.13e-03	7	139	2	IPR022735
Domain	DUF3585	MICAL1 MICALL1	1.13e-03	7	139	2	PF12130
Domain	Tropomodulin	TMOD4 TMOD1	1.13e-03	7	139	2	PF03250
Domain	CRAL-TRIO_dom	SEC14L6 ARHGAP8 SEC14L4	1.15e-03	28	139	3	IPR001251
Domain	CH	MICAL1 LCP1 MICALL1 DMD	1.40e-03	65	139	4	SM00033
Domain	MacrogloblnA2_thiol-ester-bond	A2M CPAMD8	1.50e-03	8	139	2	IPR019565
Domain	Thiol-ester_cl	A2M CPAMD8	1.50e-03	8	139	2	PF10569
Domain	MacrogloblnA2_CS	A2M CPAMD8	1.50e-03	8	139	2	IPR019742
Domain	A2M_N_2	A2M CPAMD8	1.50e-03	8	139	2	SM01359
Domain	-	A2M CPAMD8	1.50e-03	8	139	2	2.60.40.690
Domain	A2M_recep	A2M CPAMD8	1.50e-03	8	139	2	SM01361
Domain	A2M	A2M CPAMD8	1.50e-03	8	139	2	SM01360
Domain	CH	MICAL1 LCP1 MICALL1 DMD	1.84e-03	70	139	4	PF00307
Domain	-	MICAL1 LCP1 MICALL1 DMD	1.94e-03	71	139	4	1.10.418.10
Domain	CH	MICAL1 LCP1 MICALL1 DMD	2.15e-03	73	139	4	PS50021
Domain	CH-domain	MICAL1 LCP1 MICALL1 DMD	2.37e-03	75	139	4	IPR001715
Domain	A2M	A2M CPAMD8	2.38e-03	10	139	2	PF00207
Domain	A2M_N_2	A2M CPAMD8	2.38e-03	10	139	2	IPR011625
Domain	A2M_comp	A2M CPAMD8	2.38e-03	10	139	2	IPR011626
Domain	A2M_recep	A2M CPAMD8	2.38e-03	10	139	2	PF07677
Domain	A2M_comp	A2M CPAMD8	2.38e-03	10	139	2	PF07678
Domain	A2M_N	A2M CPAMD8	2.38e-03	10	139	2	PF01835
Domain	A2M_N	A2M CPAMD8	2.38e-03	10	139	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	A2M CPAMD8	2.38e-03	10	139	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	A2M CPAMD8	2.38e-03	10	139	2	PS00477
Domain	A2M_N_2	A2M CPAMD8	2.38e-03	10	139	2	PF07703
Domain	Macroglobln_a2	A2M CPAMD8	2.38e-03	10	139	2	IPR001599
Domain	CRAL-bd_toc_tran	SEC14L6 SEC14L4	3.46e-03	12	139	2	IPR001071
Domain	-	A2M CPAMD8	3.46e-03	12	139	2	1.50.10.20
Domain	CRAL_TRIO_N	SEC14L6 SEC14L4	3.46e-03	12	139	2	SM01100
Domain	ARM-type_fold	WAPL HGH1 TOGARAM2 RANBP6 BTAF1 SDAD1 PIK3R4 RRP12	3.91e-03	339	139	8	IPR016024
Domain	ARM-like	HGH1 TOGARAM2 RANBP6 BTAF1 PIK3R4 RRP12 HOMEZ	4.13e-03	270	139	7	IPR011989
Domain	CRAL/TRIO_N_dom	SEC14L6 SEC14L4	5.42e-03	15	139	2	IPR011074
Domain	EMP24_GP25L	ACBD3 SEC14L4	5.42e-03	15	139	2	PF01105
Domain	HEAT	RANBP6 BTAF1 PIK3R4	5.46e-03	48	139	3	PF02985
Domain	-	HGH1 TOGARAM2 RANBP6 BTAF1 PIK3R4 RRP12	6.39e-03	222	139	6	1.25.10.10
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	ASNSD1 A2M SART3 RANBP2 LAMB1 RANBP6 IDI1 LCP1 ELP3 POF1B MDP1 ERLIN2 PTPRF WDR97 EIF2B4 DMD ACBD3 SLC27A4	1.28e-07	974	144	18	28675297
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SART3 MICAL1 MYH11 FN1 NRCAM ADGRL1 SPIRE1 ELP3 SHANK3 CYFIP2 PIK3R4 CUL5 PHKB ERLIN2 EHD1 UGP2 TMOD1 SCRIB DMD CDH2	1.99e-06	1431	144	20	37142655
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	A2M SART3 WAPL RNF31 RPS6KB1 BTAF1 FAM111B MSN PIK3R4 CUL5 TCERG1 SCRIB SLC27A4	3.39e-06	650	144	13	38777146
Pubmed	Global landscape of HIV-human protein complexes.	UBR2 RANBP2 ACOT8 HGH1 RANBP6 MSN CUL5 NEDD8 ACBD3 SLC27A4 CYB5R1	3.49e-06	457	144	11	22190034
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ASNSD1 A2M SART3 VIL1 SEC16B MYH11 ACOT8 ERCC3 FN1 PIGK VARS2 SDAD1 DUS2 RCC1L TCERG1 SPIN1 EIF2B4 EHD1 TMOD1	4.15e-06	1371	144	19	36244648
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	FN1 LAMB1 FREM3 HMCN1 NAXE	7.11e-06	64	144	5	22261194
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	WAPL FN1 HGH1 VPS50 TOGARAM2 LCP1 SDAD1 PIK3R4 ERLIN2 RRP12 HYDIN	7.71e-06	497	144	11	36774506
Pubmed	Altered gene expression in murine branchial arches following in utero exposure to retinoic acid.	FN1 LAMB1 TGFB2 CDH2	8.13e-06	31	144	4	7601910
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	RANBP2 MYH11 WAPL HGH1 VEZT DYNC2H1 RANBP6 BTAF1 ERLIN2 PTPRF RRP12 EIF2B4 SCRIB ACBD3 SLC27A4	9.21e-06	942	144	15	31073040
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ASNSD1 A2M WAPL DYNC2H1 LAMB1 MSN PTPRF BRCA2 SPIN1 TMOD1 DMD MGA ACBD3	1.64e-05	754	144	13	35906200
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ACOT8 WAPL RNF31 VEZT VPS50 LAMB1 KIF20A ARG2 NEDD8 AURKC INTS6 TYW5 JAZF1 SCRIB MGA WDTC1	1.67e-05	1116	144	16	31753913
Pubmed	Novel functions for the endocytic regulatory proteins MICAL-L1 and EHD1 in mitosis.	MICALL1 EHD1	1.70e-05	2	144	2	25287187
Pubmed	A putative ariadne-like E3 ubiquitin ligase (PAUL) that interacts with the muscle-specific kinase (MuSK).	RNF31 MUSK	1.70e-05	2	144	2	14678832
Pubmed	NNK enhances cell migration through α7-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer.	FN1 CHRNA7	1.70e-05	2	144	2	21969082
Pubmed	Long term exposure to L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 signaling.	RPS6KB1 ARG2	1.70e-05	2	144	2	24860943
Pubmed	Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.	ARG2 DMD	1.70e-05	2	144	2	20505827
Pubmed	IDI2, a second isopentenyl diphosphate isomerase in mammals.	IDI2 IDI1	1.70e-05	2	144	2	17202134
Pubmed	Positive crosstalk between arginase-II and S6K1 in vascular endothelial inflammation and aging.	RPS6KB1 ARG2	1.70e-05	2	144	2	22928666
Pubmed	Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies.	IDI2 IDI1	1.70e-05	2	144	2	25950736
Pubmed	Segmental copy-number gain within the region of isopentenyl diphosphate isomerase genes in sporadic amyotrophic lateral sclerosis.	IDI2 IDI1	1.70e-05	2	144	2	20955688
Pubmed	Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.	DMD MUSK	1.70e-05	2	144	2	31340406
Pubmed	Isopentenyl-diphosphate isomerases in human and mouse: evolutionary analysis of a mammalian gene duplication.	IDI2 IDI1	1.70e-05	2	144	2	14629038
Pubmed	Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome.	VIL1 USH1C	1.70e-05	2	144	2	24250806
Pubmed	Tropomodulin 1 directly controls thin filament length in both wild-type and tropomodulin 4-deficient skeletal muscle.	TMOD4 TMOD1	1.70e-05	2	144	2	26586224
Pubmed	MICAL-L1 coordinates ciliogenesis by recruiting EHD1 to the primary cilium.	MICALL1 EHD1	1.70e-05	2	144	2	31615969
Pubmed	Pointed-end capping by tropomodulin modulates actomyosin crossbridge formation in skeletal muscle fibers.	TMOD4 TMOD1	1.70e-05	2	144	2	24072783
Pubmed	Mutations in CPAMD8 Cause a Unique Form of Autosomal-Recessive Anterior Segment Dysgenesis.	A2M CPAMD8	1.70e-05	2	144	2	27839872
Pubmed	Human isopentenyl diphosphate: dimethylallyl diphosphate isomerase: overproduction, purification, and characterization.	IDI2 IDI1	1.70e-05	2	144	2	8806705
Pubmed	Ontogenesis of the tear drainage system requires Prickle1-driven polarized basement membrane deposition.	FN1 LAMB1 CDH2	1.93e-05	13	144	3	33144400
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	NECTIN3 CYFIP2 MSN MICALL1 PTPRF EHD1 PLCB1 SCRIB DMD	2.95e-05	377	144	9	38117590
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	SART3 MSN NEDD8 TCERG1 SPIN1 SCRIB MGA	3.36e-05	215	144	7	35973513
Pubmed	Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2.	TGFB2 SCRIB CDH2	3.74e-05	16	144	3	17767158
Pubmed	TBX1 regulates epithelial polarity and dynamic basal filopodia in the second heart field.	FN1 SCRIB CDH2	3.74e-05	16	144	3	25371366
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SART3 RANBP2 ERCC3 WAPL FN1 RNF31 ELP3 MSN KIF20A PIK3R4 TCERG1 RRP12 EIF2B4 EHD1 SCRIB MGA SLC27A4	4.75e-05	1353	144	17	29467282
Pubmed	Mechanism for the selective interaction of C-terminal Eps15 homology domain proteins with specific Asn-Pro-Phe-containing partners.	MICAL1 EHD1	5.09e-05	3	144	2	20106972
Pubmed	α-Synuclein modulates fibronectin expression in the trabecular meshwork independent of TGFβ2.	FN1 TGFB2	5.09e-05	3	144	2	36539052
Pubmed	Lactate-upregulated ARG2 expression induces cellular senescence in fibroblast-like synoviocytes of osteoarthritis via activating the mTOR/S6K1 signaling pathway.	RPS6KB1 ARG2	5.09e-05	3	144	2	39236462
Pubmed	The N-terminal end of nebulin interacts with tropomodulin at the pointed ends of the thin filaments.	TMOD4 TMOD1	5.09e-05	3	144	2	11016930
Pubmed	Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.	CHRNA7 DMD	5.09e-05	3	144	2	24833065
Pubmed	Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin.	VIL1 JAK3	5.09e-05	3	144	2	17537734
Pubmed	IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein.	IQCJ IQCJ-SCHIP1	5.09e-05	3	144	2	17045569
Pubmed	Immunohistochemical localization of extracellular matrix proteins in developing lung tissues.	FN1 LAMB1	5.09e-05	3	144	2	17334455
Pubmed	Nedd8 modification of Cullin-5 regulates lipopolysaccharide-induced acute lung injury.	CUL5 NEDD8	5.09e-05	3	144	2	28522566
Pubmed	ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.	RPS6KB1 BRCA2	5.09e-05	3	144	2	15236312
Pubmed	alpha-Tocopherol transfer protein inhibition is effective in the prevention of cerebral malaria in mice.	SEC14L6 SEC14L4	5.09e-05	3	144	2	19923370
Pubmed	Isolation and characterization of fibronectin-alpha 1-microglobulin complex in rat plasma.	A2M FN1	5.09e-05	3	144	2	7519849
Pubmed	Expression of TGF-beta2 mRNA and PCNA, FN protein in lens epithelial cells in age-related nuclear and cortex cataract.	FN1 TGFB2	5.09e-05	3	144	2	16463680
Pubmed	Regulation of Src trafficking and activation by the endocytic regulatory proteins MICAL-L1 and EHD1.	MICALL1 EHD1	5.09e-05	3	144	2	24481818
Pubmed	Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.	MSN TGFB2	5.09e-05	3	144	2	19965872
Pubmed	Evaluation of JUN, FN1 and LAMB1 polymorphisms in pterygium in a Chinese Han population.	FN1 LAMB1	5.09e-05	3	144	2	35445627
Pubmed	Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.	SOCS6 CUL5	5.09e-05	3	144	2	24284072
Pubmed	Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers.	LRRK1 MSN	5.09e-05	3	144	2	22952686
Pubmed	Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.	A2M FN1	5.09e-05	3	144	2	27498393
Pubmed	cPLA2α and EHD1 interact and regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-containing endosomes.	MICALL1 EHD1	5.09e-05	3	144	2	22456504
Pubmed	METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.	METTL3 RRAS	5.09e-05	3	144	2	36960869
Pubmed	LRRK1 regulation of actin assembly in osteoclasts involves serine 5 phosphorylation of L-plastin.	LRRK1 LCP1	5.09e-05	3	144	2	30136304
Pubmed	Cullin neddylation may allosterically tune polyubiquitin chain length and topology.	CUL5 NEDD8	5.09e-05	3	144	2	28082425
Pubmed	MUC5B mucin production is upregulated by fibronectin and laminin in human lung epithelial cells via the integrin and ERK dependent pathway.	FN1 LAMB1	5.09e-05	3	144	2	26057585
Pubmed	Cooperation of MICAL-L1, syndapin2, and phosphatidic acid in tubular recycling endosome biogenesis.	MICALL1 EHD1	5.09e-05	3	144	2	23596323
Pubmed	Calpain-mediated proteolysis of tropomodulin isoforms leads to thin filament elongation in dystrophic skeletal muscle.	TMOD4 TMOD1	5.09e-05	3	144	2	24430868
Pubmed	Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.	FN1 CDH2	5.09e-05	3	144	2	17512904
Pubmed	Immunohistochemical study of the extracellular matrix proteins laminin, fibronectin and type IV collagen in secretory meningiomas.	FN1 LAMB1	5.09e-05	3	144	2	18474427
Pubmed	Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway.	RPS6KB1 ARG2	5.09e-05	3	144	2	25635535
Pubmed	TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts.	FN1 LAMB1 TGFB2	5.42e-05	18	144	3	23041440
Pubmed	Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2.	UBR2 WAPL NDUFAF5 HGH1 BTAF1 VARS2 IDI1 NEDD8 MRPL17 SLC27A4	6.08e-05	515	144	10	31617661
Pubmed	Vangl2-regulated polarisation of second heart field-derived cells is required for outflow tract lengthening during cardiac development.	FN1 SCRIB CDH2	8.75e-05	21	144	3	25521757
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	SART3 VIL1 RANBP2 SPIRE1 LRRK1 SDAD1 KPTN MSN MICALL1 PIK3R4 CUL5 NEDD8 RRP12 UGP2 CCNA1 SLC27A4	8.86e-05	1284	144	16	17353931
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	SART3 RANBP2 IDI1 LCP1 CYFIP2 MSN PHKB TCERG1 SPIN1 RRP12 EIF2B4 UGP2 ACBD3 NAXE WDTC1	8.93e-05	1149	144	15	35446349
Pubmed	β1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation.	FN1 LAMB1 CDH2	1.01e-04	22	144	3	38794925
Pubmed	Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis.	SEC14L6 SEC14L4	1.02e-04	4	144	2	17077281
Pubmed	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.	HGH1 FAM111B	1.02e-04	4	144	2	22814378
Pubmed	EHD3 Protein Is Required for Tubular Recycling Endosome Stabilization, and an Asparagine-Glutamic Acid Residue Pair within Its Eps15 Homology (EH) Domain Dictates Its Selective Binding to NPF Peptides.	MICALL1 EHD1	1.02e-04	4	144	2	27189942
Pubmed	A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice.	TGFB2 DMD	1.02e-04	4	144	2	25520397
Pubmed	Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.	METTL3 SOCS6	1.02e-04	4	144	2	35907010
Pubmed	Hyperglycemia-induced TGFbeta and fibronectin expression in embryonic mouse heart.	FN1 TGFB2	1.02e-04	4	144	2	15305298
Pubmed	Molecular cloning and characterization of cDNA for eukaryotic transcription factor S-II.	SEC14L6 SEC14L4	1.02e-04	4	144	2	3346229
Pubmed	Differential localization of villin and fimbrin during development of the mouse visceral endoderm and intestinal epithelium.	VIL1 LCP1	1.02e-04	4	144	2	2686960
Pubmed	Role of nectin in formation of E-cadherin-based adherens junctions in keratinocytes: analysis with the N-cadherin dominant negative mutant.	NECTIN3 CDH2	1.02e-04	4	144	2	12686612
Pubmed	Elevated Expression of Moesin in Muscular Dystrophies.	MSN DMD	1.02e-04	4	144	2	28082118
Pubmed	Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy.	TMOD4 TMOD1	1.02e-04	4	144	2	25250574
Pubmed	Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.	MICALL1 EHD1	1.02e-04	4	144	2	20801876
Pubmed	Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.	FN1 TGFB2	1.02e-04	4	144	2	20427645
Pubmed	PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway.	NOP53 RPS6KB1	1.02e-04	4	144	2	27729611
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SART3 RANBP2 PIGK NOP53 LAMB1 RANBP6 BTAF1 SDAD1 ARG2 CUL5 ERLIN2 RRP12 EIF2B4 EHD1 TMOD1 SCRIB SLC27A4	1.02e-04	1440	144	17	30833792
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	UBR2 RANBP2 ACOT8 VEZT NOP53 ELP3 SDAD1 CYFIP2 PHKB PTPRE PTPRF RRP12 SCRIB DMD	1.23e-04	1049	144	14	27880917
Pubmed	Shp2 in myocytes is essential for cardiovascular and neointima development.	MYH11 FN1 CCNA1	1.32e-04	24	144	3	31634485
Pubmed	Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy.	LAMB1 DMD	1.69e-04	5	144	2	19416897
Pubmed	MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion.	MICAL1 MICALL1	1.69e-04	5	144	2	12110185
Pubmed	Schwannomin-interacting protein-1 isoform IQCJ-SCHIP-1 is a late component of nodes of Ranvier and axon initial segments.	IQCJ IQCJ-SCHIP1	1.69e-04	5	144	2	18550753
Pubmed	Assembly of the Elongin A Ubiquitin Ligase Is Regulated by Genotoxic and Other Stresses.	CUL5 NEDD8	1.69e-04	5	144	2	25878247
Pubmed	The interaction of JRAB/MICAL-L2 with Rab8 and Rab13 coordinates the assembly of tight junctions and adherens junctions.	MICAL1 MICALL1	1.69e-04	5	144	2	18094055
Pubmed	Variants in the GH-IGF axis confer susceptibility to lung cancer.	CAMKK1 BRCA2	1.69e-04	5	144	2	16741161
Pubmed	MICAL-1 isoforms, novel rab1 interacting proteins.	MICAL1 MICALL1	1.69e-04	5	144	2	12788069
Pubmed	Neddylation controls basal MKK7 kinase activity in breast cancer cells.	RANBP2 NEDD8	1.69e-04	5	144	2	26364603
Pubmed	A HeLa-cell-encoded p21 is homologous to transcription elongation factor SII.	SEC14L6 SEC14L4	1.69e-04	5	144	2	8206389
Pubmed	Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.	FN1 DMD	1.69e-04	5	144	2	22766125
Pubmed	The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR.	LAMB1 PTPRF	1.69e-04	5	144	2	9647658
Pubmed	Rabankyrin-5 interacts with EHD1 and Vps26 to regulate endocytic trafficking and retromer function.	MICALL1 EHD1	1.69e-04	5	144	2	22284051
Pubmed	Unconventional myosin VI in the heart: Involvement in cardiac dysfunction progressing with age.	RPS6KB1 DMD CDH2	1.89e-04	27	144	3	37169038
Pubmed	Developmental gene expression profiling along the tonotopic axis of the mouse cochlea.	A2M NRCAM USH1C	2.11e-04	28	144	3	22808246
GeneFamily	Tropomodulins	TMOD4 TMOD1	1.33e-04	4	86	2	1140
GeneFamily	SEC14 family\|PRELI domain containing	SEC14L6 SEC14L4	3.31e-04	6	86	2	1063
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2M CPAMD8	7.88e-04	9	86	2	1234
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NRCAM NECTIN3 PTPRF HMCN1 MUSK	1.03e-03	161	86	5	593
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	LAMB1 TGFB2 BRCA2 DMD	4.23e-06	21	139	4	M12459
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP	MICAL1 ACOT8 SOCS6 MSN PIK3R4 RCC1L NAXE CYB5R1	1.15e-05	199	139	8	M3733
Coexpression	GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	UBR2 NDST1 CAMKK1 PIGK CHRNA7 CCNA1 DMD ARHGAP8	1.20e-05	200	139	8	M9563
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M MYH11 FN1 NRCAM LAMB1 HMCN1 LRRTM4 PLCB1 TMOD1	1.58e-08	197	143	9	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1 DMD	1.62e-07	186	143	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M MYH11 FN1 NRCAM LRRTM4 DMD CDH2	1.04e-06	164	143	7	e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell	Adult-Mesenchymal-pericyte_cell-D175\|Adult / Lineage, Cell type, age group and donor	A2M MYH11 AFF2 NRCAM LRRTM4 GZMM PLCB1	1.48e-06	173	143	7	fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	1.79e-06	178	143	7	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1 DMD	2.00e-06	181	143	7	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMKK1 LAMB1 NECTIN3 LRRTM4 TMOD1 IQCJ-SCHIP1 HYDIN	2.15e-06	183	143	7	1645d4a55cd8c22d6eb47fc5c6b1e576c454f111
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMB1 NECTIN3 FREM3 LRRTM4 TMOD1 IQCJ-SCHIP1 HYDIN	2.23e-06	184	143	7	34e316ad8e7b8667cd8ad61397281802a252744f
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	A2M FN1 NRCAM LAMB1 HMCN1 LRRTM4 DMD	2.49e-06	187	143	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	2.86e-06	191	143	7	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	2.86e-06	191	143	7	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.17e-06	194	143	7	3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.39e-06	196	143	7	c373465e34e2dd581247962d59e0477aae877079
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDST1 LRRK1 NECTIN3 POF1B MSN PTPRF TMOD1	3.39e-06	196	143	7	9790340c25f446ec655f5a0b64ec3bb44ed2e1bd
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDST1 LRRK1 NECTIN3 POF1B MSN PTPRF TMOD1	3.39e-06	196	143	7	b9ceceeacbcf81976ce92adf044f0d0aa132632b
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	A2M MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.39e-06	196	143	7	8b5337ccf74de90e8b89a02ac00671af1de2cfff
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M MYH11 FN1 PLCB1 TMOD1 DMD CDH2	3.63e-06	198	143	7	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 UPB1 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.75e-06	199	143	7	929f809579368201331d9099d8904b6e3c41797b
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M MYH11 FN1 PLCB1 TMOD1 DMD CDH2	3.75e-06	199	143	7	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 UPB1 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.75e-06	199	143	7	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	A2M MYH11 AFF2 NRCAM LAMB1 PLCB1 DMD	3.87e-06	200	143	7	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M MYH11 AFF2 NRCAM LAMB1 PLCB1 DMD	3.87e-06	200	143	7	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH11 LAMB1 TGFB2 LRRTM4 PLCB1 TMOD1 DMD	3.87e-06	200	143	7	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M MYH11 AFF2 NRCAM LAMB1 PLCB1 DMD	3.87e-06	200	143	7	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Neuronal-Excitatory-eA(LAMP5_LINC00507)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LAMB1 NECTIN3 FREM3 LRRTM4 TMOD1 IQCJ-SCHIP1 HYDIN	3.87e-06	200	143	7	0f23e72649a274043bf23e0952a9b5707c516acf
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 CC2D2B TGFB2 HMCN1 IQCJ-SCHIP1 CDH2	1.27e-05	159	143	6	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 AFF2 HMCN1 PLCB1 TMOD1 DMD	1.57e-05	165	143	6	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 TOGARAM2 FAM111B FANCB BRCA2 CCDC15	1.92e-05	171	143	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	1.92e-05	171	143	6	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 TOGARAM2 FAM111B FANCB BRCA2 CCDC15	1.92e-05	171	143	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TOGARAM2 RANBP6 LCP1 CYFIP2 GZMM KLRC1	1.98e-05	172	143	6	f3c16a62eba1ed190318beee131c71c5150b266a
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	1.98e-05	172	143	6	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 AFF2 HMCN1 PLCB1 TMOD1 DMD	2.05e-05	173	143	6	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LCA5 LAMB1 NECTIN3 FREM3 IQCJ IQCJ-SCHIP1	2.11e-05	174	143	6	9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MICAL1 DPRX LCP1 CYFIP2 SLC7A8 GZMM	2.11e-05	174	143	6	d77fa525d5c87c190b4a10787b270eabd16c610f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMB1 NECTIN3 FREM3 PTPRF TMOD1 IQCJ-SCHIP1	2.26e-05	176	143	6	212e643c50c68462d4b016428ab30eeb7868ef40
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 NRCAM LRRTM4 TMOD1 DMD CDH2	2.33e-05	177	143	6	b59967219f7d874805768e247c0eb2bc4d4420c8
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.48e-05	179	143	6	f5bb4d3a27d56698473219970e764084096cc582
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.48e-05	179	143	6	fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMB1 LRRK1 FREM3 PRDM8 IQCJ IQCJ-SCHIP1	2.56e-05	180	143	6	5e78b29fa1cbdcf502fee3577e5b45766b90d1dc
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.56e-05	180	143	6	f6a05b3751b01e74b2de8440801b0eb2e723c199
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M MYH11 NRCAM LAMB1 LRRTM4 TMOD1	2.56e-05	180	143	6	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.56e-05	180	143	6	dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 FN1 LAMB1 SLC7A8 PTPRF JAZF1	2.64e-05	181	143	6	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LCA5 LAMB1 LRRK1 NECTIN3 PRDM8 IQCJ-SCHIP1	2.72e-05	182	143	6	14a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYH11 KREMEN1 NRCAM LAMB1 SLC7A8 CDH2	2.72e-05	182	143	6	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	A2M LCP1 CYFIP2 MSN PLCB1 KLRC1	2.81e-05	183	143	6	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	2.81e-05	183	143	6	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M MGAM NRCAM HMCN1 DMD HYDIN	2.90e-05	184	143	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 AFF2 LAMB1 PLCB1 TMOD1 DMD	2.90e-05	184	143	6	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.90e-05	184	143	6	55dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M MGAM NRCAM HMCN1 DMD HYDIN	2.90e-05	184	143	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.90e-05	184	143	6	7128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH11 AFF2 LAMB1 TGFB2 DMD CDH2	2.90e-05	184	143	6	d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M MGAM NRCAM HMCN1 DMD HYDIN	2.90e-05	184	143	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LCA5 CAMKK1 LAMB1 NECTIN3 LRRTM4 HYDIN	2.90e-05	184	143	6	30fddbc9696476d4d7f08e53f84ea994a4ed873a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LCA5 CAMKK1 LAMB1 NECTIN3 LRRTM4 HYDIN	2.90e-05	184	143	6	96926efa220f03d0787322c9519bb9e8f64f74d0
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 AFF2 LAMB1 PLCB1 TMOD1 DMD	2.90e-05	184	143	6	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NDST1 POF1B PTPRE PTPRF TMOD1 ARHGAP8	3.08e-05	186	143	6	521e6e007bbae73e7328153aa170cf04ca3c1093
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.17e-05	187	143	6	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDST1 NECTIN3 LCP1 MSN PTPRE PTPRF	3.17e-05	187	143	6	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.17e-05	187	143	6	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.17e-05	187	143	6	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M FN1 DYNC2H1 TGFB2 RPS6KA6 CDH2	3.27e-05	188	143	6	116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.27e-05	188	143	6	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.27e-05	188	143	6	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	A2M AFF2 FN1 LAMB1 HMCN1 PLCB1	3.36e-05	189	143	6	9c2492c38f27e4c699b40680652e4c64911cce52
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.36e-05	189	143	6	d7ed96add29f219183c802895fbff519b627f635
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.46e-05	190	143	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.46e-05	190	143	6	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KREMEN1 NRCAM CYFIP2 PTPRF DMD CDH2	3.67e-05	192	143	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDST1 NECTIN3 TGFB2 PTPRF TMOD1 ARHGAP8	3.67e-05	192	143	6	790282d4232311df3dac4ad97c80fc53443beccc
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NDST1 NECTIN3 TGFB2 PTPRF TMOD1 ARHGAP8	3.67e-05	192	143	6	b2d9bffccd6264b4f12d88a0780646ee0b41969f
ToppCell	NS-moderate-d_07-13-Lymphoid\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LCP1 CYFIP2 MSN JAK3 GZMM KLRC1	3.67e-05	192	143	6	bd4059bfc2159f5ed8bbb2a5408b56117ca6f8e1
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 NRCAM LAMB1 LRRTM4 PLCB1	3.78e-05	193	143	6	b2abe939027a69b60d83a28d4d4cc53ba1dee4c5
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 NRCAM LAMB1 LRRTM4 PLCB1	3.78e-05	193	143	6	87ce81ff5b27d9c4300826d76ff5a62e9c408d5d
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 NRCAM LAMB1 LRRTM4 PLCB1	3.78e-05	193	143	6	d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M FN1 LAMB1 HMCN1 LRRTM4 DMD	3.78e-05	193	143	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 NRCAM LAMB1 LRRTM4 PLCB1	3.78e-05	193	143	6	41ea268e7697101fe70d8ef1045f3a43b9311739
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CPAMD8 FN1 SHANK3 CC2D2B PLCB1	3.78e-05	193	143	6	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 FN1 NRCAM LAMB1 HMCN1	3.89e-05	194	143	6	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	3.89e-05	194	143	6	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 FN1 NRCAM LAMB1 HMCN1	3.89e-05	194	143	6	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	MYH11 AFF2 LAMB1 LRRTM4 PLCB1 DMD	3.89e-05	194	143	6	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NDST1 CYP4Z1 TGFB2 PTPRE PTPRF IQCJ-SCHIP1	4.01e-05	195	143	6	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM LAMB1 HMCN1 LRRTM4 GZMM CDH2	4.01e-05	195	143	6	f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	A2M NOP53 ADGRL1 LCP1 CYFIP2 GZMM	4.01e-05	195	143	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	A2M AFF2 FN1 LAMB1 HMCN1 MUSK	4.01e-05	195	143	6	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M NOP53 ADGRL1 LCP1 CYFIP2 GZMM	4.12e-05	196	143	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M NOP53 ADGRL1 LCP1 CYFIP2 GZMM	4.12e-05	196	143	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH11 FN1 NRCAM LAMB1 TGFB2 HMCN1	4.12e-05	196	143	6	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid\|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k)	NOP53 LCP1 MSN JAK3 GZMM RPS6KA6	4.12e-05	196	143	6	6361c37b0292ba9e5bf485a4809d2b0cd894c26e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	A2M NOP53 ADGRL1 LCP1 CYFIP2 GZMM	4.12e-05	196	143	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M NOP53 ADGRL1 LCP1 CYFIP2 GZMM	4.12e-05	196	143	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RANBP2 NRCAM LAMB1 IDI1 ARG2 FAM107B	4.12e-05	196	143	6	142fd80ff74979cc2f9088fc3fcbfed374afb973
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M FN1 LAMB1 INTS6 HMCN1 MUSK	4.24e-05	197	143	6	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	4.24e-05	197	143	6	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M RANBP2 SOCS6 LCP1 SLC7A8 PTPRE	4.24e-05	197	143	6	b597c292fc1cb381a4325fed15a32966c38def28
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M MYH11 AFF2 NRCAM LAMB1 PLCB1	4.24e-05	197	143	6	01249bd485a3734de87ae6ed9c749597f39c6335
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 AFF2 NRCAM LAMB1 LRRTM4 PLCB1	4.24e-05	197	143	6	41dd312f46a2b983c8d864adeb6970c0ca4a8048
Disease	progression free survival, ovarian serous carcinoma	MGAM KREMEN1 MGA	1.54e-04	22	141	3	EFO_0004920, EFO_1001516
Disease	Malignant neoplasm of breast	MICAL1 ERCC3 FN1 NRCAM DYNC2H1 ELP3 MICALL1 PIK3R4 CUL5 PHKB BRCA2 SPATA21 PLCB1 DMD CDH2	2.01e-04	1074	141	15	C0006142
Disease	lysophosphatidylcholine measurement	MGAM LCP1 MGA MUSK	2.25e-04	62	141	4	EFO_0010224
Disease	protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 measurement	A2M POMGNT2	3.36e-04	6	141	2	EFO_0801956
Disease	infertility (implicated_via_orthology)	METTL3 BRCA2	4.69e-04	7	141	2	DOID:5223 (implicated_via_orthology)
Disease	triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation	IQCJ IQCJ-SCHIP1	6.23e-04	8	141	2	EFO_0007681, EFO_0009308
Disease	tyrosine-protein kinase receptor TYRO3 measurement	MGAM MGA	6.23e-04	8	141	2	EFO_0020829
Disease	Nerve Degeneration	CHRNA7 ARG2 ERLIN2 CDH2	6.85e-04	83	141	4	C0027746
Disease	Glaucoma	CPAMD8 TGFB2	7.98e-04	9	141	2	C0017601
Disease	level of Phosphatidylcholine (16:0_20:3) in blood serum	MYH11 MUSK	9.95e-04	10	141	2	OBA_2045075
Disease	body weight	SEC16B MGAM METTL3 NRCAM TEX35 ELP3 TGFB2 CDC123 TYW5 JAZF1 SCRIB DMD ARHGAP8 MGA HOMEZ	1.06e-03	1261	141	15	EFO_0004338
Disease	Aortic Valve Insufficiency	FN1 TGFB2	1.21e-03	11	141	2	C0003504
Disease	myocardial infarction	TDRD15 FN1 DYNC2H1 TMOD4 LCP1 PRDM8 CDC123	1.51e-03	350	141	7	EFO_0000612
Disease	HbA1c measurement	CPAMD8 RPS6KB1 FREM3 CDC123 IQCJ EIF2B4 JAZF1 PLCB1 IQCJ-SCHIP1 MUSK	1.55e-03	675	141	10	EFO_0004541
Disease	cholesteryl ester 20:3 measurement	MYH11 LCP1 MUSK	1.68e-03	49	141	3	EFO_0010347
Disease	cancer (implicated_via_orthology)	RANBP6 IDI2 IDI1 BRCA2 UGP2 SCRIB	1.87e-03	268	141	6	DOID:162 (implicated_via_orthology)
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	TDRD15 LCP1 MUSK	1.88e-03	51	141	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	Neoplasm Invasiveness	FN1 ELP3 CHRNA7 DMD CDH2	1.95e-03	184	141	5	C0027626
Disease	Tobacco Dependence	LCP1 CHRNA7	1.99e-03	14	141	2	C0040332
Disease	Fanconi anemia	FANCB BRCA2	1.99e-03	14	141	2	cv:C0015625
Disease	Nicotine Dependence	LCP1 CHRNA7	1.99e-03	14	141	2	C0028043
Disease	Nicotine Use Disorder	LCP1 CHRNA7	1.99e-03	14	141	2	C0376384
Disease	corpus callosum posterior volume measurement	IQCJ FAM107B IQCJ-SCHIP1	1.99e-03	52	141	3	EFO_0010298
Disease	coronary artery disease, factor VII measurement	TDRD15 DYNC2H1 LCP1 PRDM8	2.01e-03	111	141	4	EFO_0001645, EFO_0004619
Disease	factor VIII measurement, coronary artery disease	TDRD15 DYNC2H1 LCP1 PRDM8	2.15e-03	113	141	4	EFO_0001645, EFO_0004630
Disease	low density lipoprotein triglyceride measurement	TDRD15 LCP1	2.29e-03	15	141	2	EFO_0009946
Disease	level of Triacylglycerol (53:3) in blood serum	LCP1 MUSK	2.29e-03	15	141	2	OBA_2045165
Disease	high density lipoprotein cholesterol measurement, metabolic syndrome	LCP1 MUSK	2.29e-03	15	141	2	EFO_0000195, EFO_0004612
Disease	factor XI measurement, coronary artery disease	TDRD15 DYNC2H1 LCP1 PRDM8	2.29e-03	115	141	4	EFO_0001645, EFO_0004694
Disease	Antithrombotic agent use measurement	TDRD15 LCP1 PRDM8	2.34e-03	55	141	3	EFO_0009925
Disease	free cholesterol to total lipids in large HDL percentage	TDRD15 LCP1 MUSK	2.46e-03	56	141	3	EFO_0022279
Disease	von Willebrand factor measurement, coronary artery disease	TDRD15 DYNC2H1 LCP1 PRDM8	2.52e-03	118	141	4	EFO_0001645, EFO_0004629
Disease	diacylglycerol 36:2 measurement	LCP1 MUSK	2.60e-03	16	141	2	EFO_0010355
Disease	Eye Abnormalities	NDST1 TGFB2	2.94e-03	17	141	2	C0015393
Disease	basophil measurement	NDST1 SLC7A8 CCNA1	3.00e-03	60	141	3	EFO_0803539
Disease	free cholesterol in very large VLDL measurement	TDRD15 LCP1 MUSK	3.14e-03	61	141	3	EFO_0022274
Disease	triglycerides in medium LDL measurement	TDRD15 LCP1 MUSK	3.29e-03	62	141	3	EFO_0022322
Disease	phospholipids in very large VLDL measurement	TDRD15 LCP1 MUSK	3.29e-03	62	141	3	EFO_0022299
Disease	Bone marrow hypocellularity	FANCB BRCA2	3.30e-03	18	141	2	C1855710
Disease	diacylglycerol 36:3 measurement	LCP1 MUSK	3.30e-03	18	141	2	EFO_0020062
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	TDRD15 LCP1	3.30e-03	18	141	2	EFO_0008317, EFO_0008589
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	TDRD15 DYNC2H1 LCP1	3.44e-03	63	141	3	EFO_0001645, EFO_0004792
Disease	Hypertriglyceridemia	TDRD15 LCP1	3.68e-03	19	141	2	EFO_0004211
Disease	Juvenile Myelomonocytic Leukemia	RRAS JAK3	3.68e-03	19	141	2	C0349639
Disease	cholesterol in very large VLDL measurement	TDRD15 LCP1 MUSK	3.76e-03	65	141	3	EFO_0022230
Disease	total lipids in very large HDL measurement	TDRD15 LCP1 MUSK	3.92e-03	66	141	3	EFO_0022312
Disease	total lipids in large VLDL	TDRD15 LCP1 MUSK	4.09e-03	67	141	3	EFO_0022175
Disease	MYELODYSPLASTIC SYNDROME	FANCB BRCA2 PLCB1	4.09e-03	67	141	3	C3463824
Disease	schizophrenia (implicated_via_orthology)	SHANK3 CHRNA7 PLCB1	4.27e-03	68	141	3	DOID:5419 (implicated_via_orthology)
Disease	free cholesterol in large VLDL measurement	TDRD15 LCP1 MUSK	4.27e-03	68	141	3	EFO_0022265
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	TDRD15 LCP1 MUSK	4.45e-03	69	141	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	cholesterol in very large HDL measurement	TDRD15 LCP1 MUSK	4.45e-03	69	141	3	EFO_0022229
Disease	ascending aortic diameter	DUS2 PRDM8 HMCN1 HYDIN	4.64e-03	140	141	4	EFO_0021787

Protein segments in the cluster

Peptide	Gene	Start	Entry
IPLKHQVEYDQLTPR	USH1C	66	Q9Y6N9
YPLALNRIAAQEVPI	ACOT8	171	O14734
YQPLERLPLAQILKH	AURKC	276	Q9UQB9
VPKDDLYNNLIVNPR	ARG2	76	P78540
PKLKRQVLLYEPQVN	CUL5	641	Q93034
QVQELVFPQEEYPRK	ADGRL1	691	O94910
LYQAVEKAKPRNNPV	AFF2	451	P51816
RYKPVPALENDLALL	GZMM	101	P51124
NIARYQLGIEKLLDP	DMD	201	P11532
NVRKEPLNPLLKTIY	CC2D2B	251	Q6DHV5
KELVKNYNPLERPVA	CHRNA7	31	P36544
LIPLVYIQDPKGNRI	A2M	161	P01023
VIYSDLNLPPNPKRQ	KLRC1	6	P26715
IQPVPYRLELDQKIS	RCC1L	96	Q96I51
YADELPKPEQLAIRF	RANBP2	1271	P49792
EPNKVLYLKNLSPRV	RBM41	306	Q96IZ5
IEKYPLNLQPLESKV	IQCJ	36	Q1A5X6
QEYLKQVPSPLRELD	INTS6	591	Q9UL03
PAKKLQFYEDRQQLP	JAK3	731	P52333
LRVNKVIEINPYLLG	PSMB8	101	P28062
EELVDPYKNLPRAIF	SLC7A8	256	Q9UHI5
KEENREKNRYPNILP	PTPRE	156	P23469
NNLLPNAVYKVVLRP	KIAA0100	1961	Q14667
RFVPPALEKKYQLNL	NAXE	261	Q8NCW5
LGRLKYQAPDIDVQL	NOP53	406	Q9NZM5
PVPNLRNLDLSYNKL	LRRTM4	131	Q86VH4
EEKEGIPPQQQRLIY	NEDD8	31	Q15843
DLRVVQKYPLLKEPQ	MGA	536	Q8IWI9
QSPKDYIIDPRENIV	NRCAM	51	Q92823
RLYPEVPEVLKRLQS	MDP1	46	Q86V88
RKNEFPVIVRLPLYA	LRRK1	186	Q38SD2
PAKQLLPLERVYQEI	CAMKK1	186	Q8N5S9
YIGKDAFRPLPQLQE	LRRC53	171	A6NM62
LLQYGILEREKNPIN	ASB17	166	Q8WXJ9
DPNKNRYEVPVPLNI	MGAM	1056	O43451
DPRVLEKQELQQPTY	JAZF1	41	Q86VZ6
NPEYQKLGIDPINER	ATXN3L	96	Q9H3M9
RVYALPEDLVEVNPK	LCP1	596	P13796
KIRPVAKELQFNYIP	KPTN	61	Q9Y664
TEYPLNLPVEDIQKR	MORC3	391	Q14149
LRLQTLPPVQLAQKY	NDST1	556	P52848
NLPPYLTQEARDLLK	RPS6KB1	311	P23443
IEDPYSPRIQNLLKI	LAMB1	216	P07942
RELQDSRNLKYPVLP	LCA5	476	Q86VQ0
VLYQAVKEELPQERP	KREMEN1	316	Q96MU8
FPLIKRKVQADQYIP	MICALL1	666	Q8N3F8
PNQVRDLYDVLAKEP	MICAL1	476	Q8TDZ2
YLAGDKLLPQRVLEQ	MSN	146	P26038
ANKPLLDEIVPVYRR	ACBD3	471	Q9H3P7
QLGIVYRDLKPENIL	RPS6KA6	191	Q9UK32
APALRIDYPKALQIL	POMGNT2	46	Q8NAT1
PFQNILPRVYIKEGE	CYFIP2	1051	Q96F07
VKRLPEYPQVDDLLL	EIF2B4	141	Q9UI10
IRKYVVQNPEQEPLS	POF1B	136	Q8WVV4
LILYPNLKVPANDFI	DPRX	131	A6NFQ7
EPLKYAEQLPVAQII	PIGK	341	Q92643
LLDPDVVARFKQRYP	METTL3	556	Q86U44
TKPNIPEAIRRNYEL	ERLIN2	171	O94905
EKQRDIDLRVYVPPN	HMCN1	2091	Q96RW7
PVLNPLIYTLRNKEV	OR12D1	276	P0DN82
EDKQENRYLVVPPLE	FANCB	381	Q8NB91
VPVLNPLIYSLRNKD	OR8B12	281	Q8NGG6
LQYSKLQERKPEILP	DYNC2H1	971	Q8NCM8
YLLLVRKNVTLNPDP	IDI2	151	Q9BXS1
NLIAVPDKNYIRPEI	IL37	76	Q9NZH6
YEVPLILRNNDKIPR	HYDIN	116	Q4G0P3
YILLVRKNVTLNPDP	IDI1	151	Q13907
YAVKAQLDPPLLAVL	BRCA2	2726	P51587
YKIPVPINAELRKYQ	BTAF1	1256	O14981
VILPLPQNVKDYLLD	CDC123	26	O75794
NIPDLLPGRKYIVNV	FN1	776	P02751
HLPLPDLQEVKRVLY	UPB1	16	Q9UBR1
LPDKLQQARLPVVDY	CELA3A	171	P09093
YIEDDNPELIRPQKL	FAM107B	6	Q9H098
VQRVLVPAYAKQLSP	C14orf93	211	Q9H972
LRPVNEKLEAYILDP	CPAMD8	156	Q8IZJ3
LDIPHRPQQAIREKY	CCNA1	431	P78396
RLVDIIAAVPPQYRK	ELP3	56	Q9H9T3
NEAKLYLEKPVVPLN	ASNSD1	231	Q9NWL6
INIDLKPTAVLRPYQ	ERCC3	306	P19447
YQKLEQITGLPRPEI	HOMEZ	386	Q8IX15
EKLAQPVYETVQRPL	DUS2	381	Q9NX74
TVIPLNERLKKYPND	FAM111B	591	Q6SJ93
VAEGLRQLYAQKLLP	EHD1	21	Q9H4M9
KPYEEALLQAEAPRL	SART3	296	Q15020
NYPETLKNLIVIRAP	SEC14L4	181	Q9UDX3
NYPEILKSLIVVRAP	SEC14L6	181	B5MCN3
YFAPNPKIIRQEEGL	CDH2	496	P19022
PPLNIHYLKLIDREN	COA1	66	Q9GZY4
PVQRYVPLKDQRNVS	PHKB	466	Q93100
ERLKPYVAAQLDVLP	PTPRF	1181	P10586
LPVDLQYLPPDKQRE	HGH1	266	Q9BTY7
KDPILHVLRQYLDPA	METTL26	11	Q96S19
ELRELKIAYQPPAEN	FREM3	381	P0C091
DPQIQLPLLAARRYK	VARS2	991	Q5ST30
RLRLQKLPYNPQQEE	SPATA21	356	Q7Z572
YDLIRPQIKDLPQPQ	TDRD15	1276	B5MCY1
LAVLVASVYPRKPQA	TOGARAM2	906	Q6ZUX3
RLYPAAADPLAVKLQ	PRDM8	536	Q9NQV8
LQNLIKRDPPAYIEE	SDAD1	16	Q9NVU7
LQPLKLDYRALAAVP	SCRIB	1261	Q14160
IEKYPLNLQPLESKV	IQCJ-SCHIP1	36	B3KU38
DLPRALEQIHYILKP	NDUFAF5	166	Q5TEU4
PQVTLLDPNEKYLLR	CYB5R1	36	Q9UHQ9
IPLLNPVIYSLRNKD	OR5T2	321	Q8NGG2
DFQQYLPLVIEPLIK	RANBP6	626	O60518
EPLNFLDPKVAQRVL	RRP12	1116	Q5JTH9
KRNKIPIDNYPIQTL	SPATA1	6	Q5VX52
LPRDQGYLPKDQNIL	CCDC15	586	Q0P6D6
LELRVPLKFPVQENA	C12orf4	26	Q9NQ89
ERYDLRNIVQPKPLP	C11orf1	76	Q9H5F2
YAPVVNISRLLDKPI	CYP4Z1	376	Q86W10
IKALELDPNLYRIGQ	MYH11	751	P35749
PPAYQARLLQKLTEE	RNF31	1046	Q96EP0
ALVKEVPRNDINIYP	PIK3R4	446	Q99570
NPKARVPEQRIELYQ	TGFB2	156	P61812
KYELEKLPPVLNLQE	VPS50	71	Q96JG6
KLPPVLNLQELEAYR	VPS50	76	Q96JG6
LDQKYNGEPVQIRVP	VIL1	466	P09327
PVKLPDYNNRLRVLV	WDTC1	256	Q8N5D0
VELPPYLERVKQQAN	WDTC1	356	Q8N5D0
IQPYEKIKARGLPDN	UGP2	86	Q16851
VPRNLDLAQNPDLYK	SPEM3	686	A0A1B0GUW6
KFLDEERLLQEYPPN	SHANK3	66	Q9BYB0
DPRYLLLNPKERKQV	TCERG1	691	O14776
AQVLEKELPLYARPI	SLC27A4	566	Q6P1M0
RNIPIPTLKAYAEAL	TMOD1	206	P28289
ELLYDLLEPPSQQRK	KIF20A	311	O95235
VLDQVPVNPSLYLIK	SPIN1	76	Q9Y657
LKKVQERQYNPLPIE	SPIRE1	286	Q08AE8
VRELYSPLAQLPAKV	WDR97	411	A6NE52
LEKLPVNEKTYRPLN	PPIL3	131	Q9H2H8
PAKLIVYLQRFRPQD	THTPA	191	Q9BU02
LQVPKYLPQEQRFDI	WAPL	966	Q7Z5K2
RNPPARIKAAYQALE	ST7L	216	Q8TDW4
PYIQPKREIPAEEQI	TMOD4	96	Q9NZQ9
PRLNEILYPPLKQEQ	PLCB1	256	Q9NQ66
LEKYKRQPPVANLIN	SEC16B	396	Q96JE7
KYDQLVIPPEVLRYD	ARHGAP8	181	P85298
EFRRNYQIPAKIPEL	TEX26	181	Q8N6G2
EAYPILEQKLKLIQP	VEZT	466	Q9HBM0
LVRAVRKYQEQELPP	RRAS	186	P10301
IRYPRESNKLINLPE	UBR2	1591	Q8IWV8
NYKLPLRRAPKEQQE	TEX35	111	Q5T0J7
ELANPNKRAPVRIVY	THEGL	421	P0DJG4
YTRIDLIQKLPLPNK	SOCS6	511	O14544
QHLYPQRKPLVLEGI	TYW5	21	A2RUC4
IPKLFQVLAPRYKDQ	MRPL17	86	Q9NRX2
LNPKLLSLEYPRNNI	MUSK	561	O15146
NPVNNLIRKDYLEEP	NECTIN3	476	Q9NQS3